High materiality7/10
DexCom (DXCM) PT Raised to $90 at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: Target $90; price $83.45; RBC Capital.
- Target $90; price $83.45; upside ~8%.
Key facts
- 01
Target: $90
- 02
Posted price: $83.45
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.